Victrex (VCT) AI Stock Analysis

• Market Cap: £561.87M
• Dividend Yield: 9.56%
• Average Volume (3M): 301.81K
• Price to Earnings (P/E): 20.2
• Beta (1Y): 1.38
• Revenue Growth: 0.58%
• EPS Growth: 61.53%
• Country: UK
• Employees: 1,131
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.18
• Shares Outstanding: 87,052,110
• 10 Day Avg. Volume: 270,673
• 30 Day Avg. Volume: 301,805
• PEG Ratio: 0.38
• Price to Book (P/B): 1.44
• Price to Sales (P/S): 2.11
• P/FCF Ratio: 12.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £737.50
• Price Target Upside: 13.11% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 6
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: 714.00p ▲(9.51% Upside)

Victrex's overall stock score reflects a stable financial position with strong equity and low leverage. Technical indicators suggest short-term bullish momentum, while valuation is favorable with a high dividend yield. However, challenges in revenue growth, profitability, and recent earnings call concerns weigh on the score.

Positive Factors

Strong Balance Sheet

Victrex's low leverage and high equity ratio indicate financial stability, providing resilience against economic fluctuations and enabling strategic investments.

High Cash Conversion

Effective cash management and operational efficiency ensure liquidity and the ability to fund growth initiatives, supporting long-term business sustainability.

Mega-Programme Milestone

This milestone indicates potential for significant growth opportunities, enhancing Victrex's market position and driving future revenue streams.

Negative Factors

Declining Revenue

The decline in revenue suggests challenges in market demand or competitive pressures, which could impact long-term profitability and market share.

Operational Challenges in China

Operational issues in China could hinder production efficiency and growth in a key market, affecting overall company performance and strategic expansion plans.

Decline in Medical Revenues

Continued challenges in the Medical segment, particularly in Spine, may limit growth in a high-margin sector, affecting overall revenue diversification.

Victrex Business Overview & Revenue Model

Company Description

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. It serves automotive, aerospace, energy and industrial, manufacturing and engineering, electronics, and medical markets. Victrex plc was founded in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.

How the Company Makes Money

Victrex generates revenue primarily through the sale of its high-performance polymer products, with major revenue streams stemming from its key sectors: automotive, aerospace, medical, and electronics. The company leverages its proprietary technology and extensive industry expertise to develop customized solutions that meet specific customer needs. Significant partnerships with leading companies in these sectors enhance its market reach and application development. Additionally, Victrex's revenue is bolstered by its focus on innovation and continuous improvement, enabling it to maintain competitive pricing and expand its product offerings in response to evolving market demands.

Victrex Financial Statement Overview

Summary

Victrex shows a stable financial position with strong equity and low leverage. However, challenges in revenue growth and profitability are evident, with declining margins and cash flow generation. The balance sheet remains robust, but operational efficiency and cash management need improvement.

Income Statement

Victrex's income statement shows a decline in revenue and profitability over the past year, with a negative revenue growth rate of -0.40% and decreasing margins. The gross profit margin stands at 44.73%, and the net profit margin is 9.38%. The EBIT and EBITDA margins are 13.43% and 20.61%, respectively, indicating a reduction in operational efficiency compared to previous years. Despite these challenges, the company maintains a reasonable level of profitability.

Balance Sheet

The balance sheet of Victrex reflects a strong equity position with a debt-to-equity ratio of 0.11, indicating low leverage. The return on equity is 6.41%, which has decreased over the years, suggesting reduced profitability from shareholders' investments. The equity ratio is 76.47%, highlighting a solid financial structure with significant equity backing the company's assets.

Cash Flow

Victrex's cash flow statement reveals a decrease in free cash flow growth by -23.68%, indicating potential challenges in generating cash. The operating cash flow to net income ratio is 2.56, suggesting efficient cash generation from operations. However, the free cash flow to net income ratio is 1.77, showing a decline in cash available after capital expenditures.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	292.70M	296.40M	296.20M	307.00M	341.00M	306.30M
Gross Profit	128.60M	132.60M	134.30M	162.60M	174.70M	157.00M
EBITDA	68.60M	61.10M	69.70M	96.00M	120.80M	115.50M
Net Income	27.80M	27.80M	17.20M	61.70M	76.20M	73.20M
Balance Sheet
Total Assets	566.90M	566.90M	592.00M	626.60M	641.60M	615.30M
Cash, Cash Equivalents and Short-Term Investments	24.20M	24.20M	29.30M	33.50M	68.80M	112.40M
Total Debt	49.00M	49.00M	50.40M	50.20M	32.10M	15.90M
Total Liabilities	135.70M	135.70M	130.40M	125.60M	151.00M	103.60M
Stockholders Equity	433.50M	433.50M	461.00M	499.00M	488.80M	509.20M
Cash Flow
Free Cash Flow	48.90M	49.30M	51.40M	2.30M	34.50M	85.20M
Operating Cash Flow	70.70M	71.10M	84.00M	40.80M	80.00M	127.10M
Investing Cash Flow	-21.80M	-21.80M	-35.40M	-32.30M	-16.20M	-83.20M
Financing Cash Flow	-53.70M	-54.60M	-51.90M	-32.80M	-82.40M	-41.70M

Victrex Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 652.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:VCT, the sentiment is Negative. The current price of 652 is above the 20-day moving average (MA) of 631.05, above the 50-day MA of 642.24, and below the 200-day MA of 743.59, indicating a neutral trend. The MACD of 4.78 indicates Negative momentum. The RSI at 51.67 is Neutral, neither overbought nor oversold. The STOCH value of 35.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:VCT.

Victrex Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VCT	70 Outperform	£561.87M	20.21	6.22%	9.56%	0.58%	61.53%
TET	67 Neutral	£121.74M	11.19	8.02%	4.07%	1.12%	-0.70%
CRDA	65 Neutral	£3.80B	27.18	6.17%	3.48%	2.36%	-13.99%
ELM	64 Neutral	£954.95M	-16.81	3.37%	1.33%	-11.78%	-92.61%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
JMAT	60 Neutral	£3.43B	-26.64	-5.62%	3.77%	-4.60%	-126.46%
SYNT	51 Neutral	£101.57M	-1.15	-7.26%	―	-4.41%	2.29%

Victrex Corporate Events

Victrex PLC Updates Share Capital and Voting Rights

Victrex PLC announced that as of 31 October 2025, its issued share capital comprises 87,052,107 ordinary shares, each with one vote, and no shares are held in treasury. This update provides shareholders with the necessary information to calculate their interests in the company, which is crucial for maintaining transparency and compliance with regulatory requirements.

The most recent analyst rating on (GB:VCT) stock is a Buy with a £9.40 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.

Victrex Announces CEO Succession with Dr. James Routh

Victrex plc has announced that Dr. James Routh will assume the role of Chief Executive Officer starting January 1, 2026, succeeding Jakob Sigurdsson. This transition is part of a planned succession, with Sigurdsson remaining on the board until the company’s Annual General Meeting in February 2026 to ensure a smooth handover. The announcement is significant for Victrex as it continues to strengthen its leadership team, which is crucial for maintaining its position as a leader in the high-performance polymer solutions industry.

The most recent analyst rating on (GB:VCT) stock is a Buy with a £9.40 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.

Victrex PLC Updates Share Capital and Voting Rights

Victrex PLC announced that as of 30 September 2025, its issued share capital consists of 87,052,107 ordinary shares, each carrying one vote, with no shares held in treasury. This update on voting rights and capital is crucial for shareholders to determine their interest or any changes in their interest in the company.

The most recent analyst rating on (GB:VCT) stock is a Buy with a £774.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.

Victrex PLC Updates Share Capital and Voting Rights

Victrex PLC, a company known for its advanced materials and polymer solutions, has announced that as of 29 August 2025, its issued share capital consists of 87,052,107 ordinary 1p shares, each carrying one vote, with no shares held in treasury. This update on the company’s voting rights and capital structure provides shareholders with the necessary information to assess their interests and any changes therein, potentially impacting shareholder decisions and the company’s market positioning.

The most recent analyst rating on (GB:VCT) stock is a Hold with a £742.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.